how much weight should i expect to lose on tirzepatide Adults with obesity using maintain 'remarkable' loss at 88 weeks Best Time of Day to

Three areas of the body are approved for semaglutide injections: The abdomen

Testing may be appropriate if: Weight loss exceeds 1520% Fatigue, hair thinning or neuropathy develops Persistent vomiting or diarrhoea occurs Dietary intake becomes severely restricted You are in a higher-risk group (e.g., premenopausal women, older adults, GLP-1 + metformin users) Monitoring should be personalised rather than automatic

Tirzepatide activates both GLP-1 and GIP receptors, with GIP adding additional glucose-dependent insulin stimulation and potential satiety effects, based on clinical trial data

Tirzepatide works like two hormone, GLP-1 and another one called GIP, which together help the body release insulin, control blood sugar, and manage weight

Rushing the titration increases gastrointestinal side effect risk without improving outcomes

Whole-body Joints, gut & tissue